ArticleAJPM focus2026
Cardiovascular-Kidney-Metabolic Syndrome and Health Risk Behaviors in U.S. Adults.
Article in AJPM focus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cigarette smoking, vaping, and excessive alcohol consumption are established risk factors for many diseases, but few studies have examined these health-risk behaviors in relation to cardiovascular-kidney-metabolic syndrome. This study aims to assess the odds of current smoking, vaping, and heavy drinking by cardiovascular-kidney-metabolic syndrome stage and whether the odds vary by sex. Methods: This cross-sectional study used pooled data on 538,123 adults from the 2021 and 2023 waves of the Behavioral Risk Factor Surveillance System survey. Multivariable binomial logistic models stratified by sex and age group were estimated to assess the predicted probabilities of respective health risk behaviors for cardiovascular-kidney-metabolic syndrome stages, determined by self-reported health conditions. In addition, the interaction between sex and cardiovascular-kidney-metabolic syndrome stage was assessed to determine whether there were differences between males and females at different cardiovascular-kidney-metabolic syndrome stages. Results: The likelihood of current smoking and vaping was higher among those with an advanced cardiovascular-kidney-metabolic syndrome stage (i.e., 4) than among adults with lower cardiovascular-kidney-metabolic syndrome stages (i.e., 0, 1). Although males had a higher likelihood of smoking and vaping at cardiovascular-kidney-metabolic syndrome stages 0 and 1, no differences between males and females were found at cardiovascular-kidney-metabolic syndrome Stage 4. In contrast, the likelihood of heavy drinking was lower among females at cardiovascular-kidney-metabolic syndrome Stage 4 and higher among males at cardiovascular-kidney-metabolic syndrome Stages 2 and 3 than among those at lower cardiovascular-kidney-metabolic syndrome stages. Conclusions: Findings of this observational study suggest a higher likelihood of smoking and vaping among adults with advanced cardiovascular-kidney-metabolic syndrome stages, highlighting the scope for improving awareness about health-risk behaviors among patients to help them better manage their cardiovascular-kidney-metabolic syndrome conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.